Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals (Q36141214)

12 August 2017

1 reference

title

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals (English)

1 reference

12 August 2017

0 references

anti-retroviral agent

0 references

2

Linda-Gail Bekker

1 reference

12 August 2017

1

Stephen D Lawn

1 reference

12 August 2017

Robert F Miller

3

1 reference

PubMed ID

15919622

12 August 2017

language of work or name

1 reference

1 June 2005

1 reference

Lancet Infectious Diseases

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

6

1 reference

12 August 2017

361-373

1 reference

Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immunorestitution diseases in patients not infected with HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immunorestitution disease involving the innate and adaptive response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Pulmonary tuberculosis in AIDS patients: transient chest radiographic worsening after initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical Clinical Improvement and Radiographic Deterioration in Anergic Patients Treated for Far-Advanced Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Elevated serum concentrations of soluble CD14 in HIV- and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Cytokine/chemokine cascades in immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Restraining mycobacteria: role of granulomas in mycobacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Type 1/Type 2 immunity in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune restoration and CD4+ T-cell function with antiretroviral therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Assessment of Type 1 and Type 2 Cytokines in HIV Type 1-Infected Individuals: Impact of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterial cutaneous manifestations: a new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Pyomyositis and Cutaneous Abscesses Due toMycobacterium avium:An Immune Reconstitution Manifestation in a Patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterial lymphadenitis associated with the initiation of combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterial Lymphadenitis after Initiation of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium avium complex lymph node abscess after use of highly active antiretroviral therapy in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Focal adenitis developing after immune reconstitution with HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Hypercalcemia: A Manifestation of Immune Reconstitution Complicating Tuberculosis in an HIV‐Infected Person

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Primary septic arthritis and osteomyelitis due to Mycobacterium avium complex in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Localized Mycobacterium avium intracellulare psoas abscess in patients with AIDS after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Localized Mycobacterium avium complex infection in a patient on HAART

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Deterioration of disseminated cutaneous Mycobacterium avium complex infection with a leukaemoid reaction following institution of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium avium Infection and Immune Restoration Disease After Highly Active Antiretroviral Therapy in a Patient with HIV and Normal CD4+ Counts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Isolated pulmonary Mycobacterium avium complex infection in patients with human immunodeficiency virus infection: case reports and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Military tuberculosis with paradoxical expansion of intracranial tuberculomas complicating human immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Exacerbation of the inflammatory response to Mycobacterium tuberculosis after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical reactions in HIV and pulmonary TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Systemic inflammatory reaction after starting highly active antiretroviral therapy in AIDS patients treated for extrapulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical worsening of tuberculosis in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Development of multiple abscesses in an HIV/TB co-infected patient after initiation of antituberculous and highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Inflammatory paradoxical reaction occurring in tuberculosis patients treated with HAART and rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Prolonged paradoxical reaction of tuberculosis in an HIV-infected patient after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Paradoxical reaction during treatment of tuberculous brain abscess in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune reactivation and paradoxical worsening in an HIV-infected tuberculosis patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Acute renal failure on immune reconstitution in an HIV-positive patient with miliary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Nodular densities after HAART introduction in an AIDS patient.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Acute respiratory failure due to Mycobacterium kansasii infection: immune reconstitution disease in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Immune Reconstitution Inflammatory Syndrome Associated With HIV and Leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Regional Bacillus Calmette-Guérin lymphadenitis after initiating antiretroviral therapy in an infant with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Human Immunodeficiency Virus Type 1-Related Pulmonary Mycobacterium xenopi Infection: A Need to Treat?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970140-7

7 January 2021

10.1016/S1473-3099(05)70140-7

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15919622